- Home
- ASPN vs ELVN Comparison
ASPN vs ELVN Comparison
Compare ASPN & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPN
- ELVN
- Stock Information
- Founded
- ASPN 2001
- ELVN 2016
- Country
- ASPN United States
- ELVN United States
- Employees
- ASPN N/A
- ELVN N/A
- Industry
- ASPN RETAIL: Building Materials
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- ASPN Consumer Discretionary
- ELVN Health Care
- Exchange
- ASPN Nasdaq
- ELVN Nasdaq
- Market Cap
- ASPN 486.5M
- ELVN 927.8M
- IPO Year
- ASPN 2014
- ELVN 2020
- Fundamental
- Price
- ASPN $6.14
- ELVN $19.65
- Analyst Decision
- ASPN Strong Buy
- ELVN Strong Buy
- Analyst Count
- ASPN 10
- ELVN 5
- Target Price
- ASPN $21.78
- ELVN $39.60
- AVG Volume (30 Days)
- ASPN 1.4M
- ELVN 715.5K
- Earning Date
- ASPN 08-06-2025
- ELVN 08-12-2025
- Dividend Yield
- ASPN N/A
- ELVN N/A
- EPS Growth
- ASPN N/A
- ELVN N/A
- EPS
- ASPN N/A
- ELVN N/A
- Revenue
- ASPN $436,921,000.00
- ELVN N/A
- Revenue This Year
- ASPN N/A
- ELVN N/A
- Revenue Next Year
- ASPN $24.31
- ELVN N/A
- P/E Ratio
- ASPN N/A
- ELVN N/A
- Revenue Growth
- ASPN 51.90
- ELVN N/A
- 52 Week Low
- ASPN $4.16
- ELVN $13.30
- 52 Week High
- ASPN $33.15
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- ASPN 52.44
- ELVN 46.72
- Support Level
- ASPN $5.72
- ELVN $20.22
- Resistance Level
- ASPN $6.21
- ELVN $21.90
- Average True Range (ATR)
- ASPN 0.32
- ELVN 1.55
- MACD
- ASPN -0.01
- ELVN -0.24
- Stochastic Oscillator
- ASPN 55.56
- ELVN 20.07
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.